BioCatalystWatch
NMRAWorkspace / NMRA / OverviewCompany library
Neumora Therapeutics, Inc. logo

Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc. (NMRA)

Website

Price
Market cap
Next catalystExpected 2H 2026NMRA-898 — Phase 1 SAD/MAD · Phase 1 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

NMRA-215

NLRP3

PreINDP1P2P3FilingApproved

NMRA-898

M4R

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

NMRA-898

M4R

PreINDP1P2P3FilingApproved
Upcoming / outlook

NMRA-215

NLRP3

PreINDP1P2P3FilingApproved

Other pipelines

V1aR

PreINDP1P2P3FilingApproved
NMRA-215

NLRP3

PreINDP1P2P3FilingApproved
NMRA-861

M4R

PreINDP1P2P3FilingApproved
NMRA-CK1δ

CK1δ

PreINDP1P2P3FilingApproved
NMRA-GCASE

GCase

PreINDP1P2P3FilingApproved

History / paused

KOR

PreINDP1P2P3FilingApproved

KOR

PreINDP1P2P3FilingApproved

M4R

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NMRA PR & News

PR & News

NMRA SEC archive